22 results · 70ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

LEICA BIOSYSTEMS

FDA Adverse Event
Malfunction ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MVU·December 23, 2015

BOND ORACLE HER2 IHC SYSTEM

FDA Adverse Event
Malfunction ·LEICA BIOSYSTEMS NEWCASTLE LTD.·Product code MVC·October 13, 2015

LEICA BIOSYSTEMS

FDA Adverse Event
Malfunction ·LEICA BIOSYSTEMS NEWCASTLE LTD.·Product code MYA·November 18, 2015

BOND AND NOVOCASTRA

FDA Adverse Event
Malfunction ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MYA·March 9, 2012

LEICA BIOSYSTEMS

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MYA·December 26, 2018

ESTROGEN RECEPTOR CLONE 6F11 READY-TO-USE PRIMARY ANTIBODY FOR BOND

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MYA·July 2, 2021

ESTROGEN RECEPTOR CLONE 6F11 READY-TO-USE PRIMARY ANTIBODY FOR BOND

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MYA·July 2, 2021

ESTROGEN RECEPTOR CLONE 6F11 READY-TO-USE PRIMARY ANTIBODY FOR BOND¿

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MYA·January 10, 2024

BOND ORACLE HER2 IHC SYSTEM

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MVC·February 10, 2016

BOND ORACLE HER2 IHC SYSTEM

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD.·Product code MVC·February 10, 2016

ESTROGEN RECEPTOR CLONE 6F11 READY-TO-USE PRIMARY ANTIBODY FOR BOND¿

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MYA·January 10, 2024

BOND ORACLE HER2 IHC SYSTEM

FDA Adverse Event
Malfunction ·LEICA BIOSYSTEMS NEWCASTLE LTD.·Product code MVC·August 27, 2013

BOND AND NOVOCASTRA

FDA Adverse Event
Malfunction ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code NJT·February 6, 2012

ESTROGEN RECEPTOR CLONE 6F11 READY-TO-USE PRIMARY ANTIBODY FOR BOND¿

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MYA·November 7, 2023

BOND¿ READY-TO-USE PRIMARY ANTIBODY C-ERBB-2 ONCOPROTEIN

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code NJT·January 28, 2022

LEICA BIOSYSTEMS

FDA Adverse Event
Malfunction ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code NJT·December 4, 2015

LEICA BIOSYSTEMS

FDA Adverse Event
Malfunction ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code MVU·October 7, 2015

BOND¿ READY-TO-USE PRIMARY ANTIBODY C-ERBB-2 ONCOPROTEIN

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code NJT·January 28, 2022

BOND¿ READY-TO-USE PRIMARY ANTIBODY C-ERBB-2 ONCOPROTEIN

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code NJT·January 28, 2022

BOND¿ READY-TO-USE PRIMARY ANTIBODY C-ERBB-2 ONCOPROTEIN

FDA Adverse Event
Injury ·LEICA BIOSYSTEMS NEWCASTLE LTD·Product code NJT·January 28, 2022